Literature DB >> 12214831

Loading dose versus standard regime of magnesium sulfate in the management of eclampsia: a randomized trial.

Mosammat Rashida Begum1, Anowara Begum, Ehsan Quadir.   

Abstract

OBJECTIVE: To determine whether only loading dose of magnesium sulfate is effective in controlling convulsion in eclampsia. STUDY
METHODS: This prospective study was conducted in Dhaka Medical College and Hospital, Bangladesh between July and November 1999. Eclamptic patients who were eligible for magnesium sulfate (MgSO4) therapy were randomly assigned by lottery to receive either only loading dose (n = 202) or standard regime (n = 199) of MgSO4. Besides the anticonvulsant, patients of both the groups were managed by same protocol for eclampsia management prepared by Eclampsia Working Group, Bangladesh. Efficacy of both the regimes was assessed by measuring the rate of recurrent convulsion. Results were expressed as mean +/- SD and a proportion. Statistical analysis was done using unpaired t-test, Z-test and chi2 test as appropriate. A P-value of < 0.05 was considered significant.
RESULTS: At the time of randomization there were no significant differences between the two groups in terms of age (22.40 +/- 4.21 vs 22.49 +/- 4.67 years), parity (72.77% vs 70.35% primi), type of eclampsia (84.65% vs 85.42% antepartum eclampsia), number of convulsions (5.30 +/- 3.26 vs 5.48 +/- 3.32 times), gestational age (35.65 +/- 3.37 vs 35.13 +/- 3.26 weeks), systolic blood pressure (153.19 +/- 20.19 vs 154.17 +/- 22.32 mmHg), diastolic blood pressure (106.23 +/- 13.84 vs 105.60 +/- 12.88 mmHg), proteinuria (70.80% vs 72.36% had > + proteinuria) and Glasgow Coma Scale (GCS) (73.26% vs 75.88% > 8) for the loading and standard regime groups. There were also no differences between the two groups in mean fit and treatment interval (6.88 +/- 5.26 vs 7.12 +/- 4.29h), fit and delivery interval (11.35 +/- 10.22 vs 11 +/- 6.69h) and return of consciousness (10.94 +/- 8.29 vs 11.24 +/- 8.37h). The recurrent convulsion rate was almost the same in both the groups (3.96% in loading vs 3.51% in standard regime, P > 0.05). Case fatality rate was 4.45% and 5.02% in loading and standard regime groups, respectively (P > 0.05).
CONCLUSION: Only loading dose of MgSO4 can control convulsion in eclampsia and it is as effective as standard regime.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12214831     DOI: 10.1046/j.1341-8076.2002.00029.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  7 in total

Review 1.  Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.

Authors:  Lelia Duley; A Metin Gülmezoglu; David J Henderson-Smart; Doris Chou
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

2.  Single Loading Low Dose MgSo4 Regimen: A Simple, Safe and Effective Alternative to Pritchard's Regimen for Indian Women.

Authors:  Tripti Nagaria; Subarna Mitra; Sashi Prabha Banjare
Journal:  J Clin Diagn Res       Date:  2017-08-01

Review 3.  Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.

Authors:  Lelia Duley; Hosam E Matar; Muhammad Qutayba Almerie; David R Hall
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

4.  Risk factors for maternal mortality associated with eclampsia presenting at a Nigerian tertiary hospital.

Authors:  Kabiru Afolarin Rabiu; Adeniyi Abiodun Adewunmi; Tawakwalit Abimbola Ottun; Fatimat Motunrayo Akinlusi; Adewunmi Adeoye Adebanjo; Taiwo Ganiyat Alausa
Journal:  Int J Womens Health       Date:  2018-11-06

5.  Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis.

Authors:  Emily Shepherd; Rehana A Salam; Deepak Manhas; Anne Synnes; Philippa Middleton; Maria Makrides; Caroline A Crowther
Journal:  PLoS Med       Date:  2019-12-06       Impact factor: 11.069

6.  Open-labelled randomised controlled trial of 12 hours versus 24 hours modified Pritchard regimen in the management of eclampsia and pre-eclampsia in Ghana (MOPEP Study): study protocol.

Authors:  Titus Beyuo; Emma Lawrence; Elizabeth S Langen; Samuel A Oppong
Journal:  BMJ Open       Date:  2019-10-22       Impact factor: 2.692

7.  Magnesium sulphate therapy in eclampsia: the Sokoto (ultra short) regimen.

Authors:  Bissallah A Ekele; Danjuma Muhammed; Lawal N Bello; Ibrahim M Namadina
Journal:  BMC Res Notes       Date:  2009-08-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.